“…Biopolymer-based scaffolds have been proposed in tissue engineering to replace and restore damaged tendon tissue because they possess the ability to mimic the structural, biochemical, and biomechanical functions of the extracellular matrix (ECM), consequently mimicking the native tissues. In particular, in orthopedic tissue regeneration, biodegradable polymeric implants based on poly- d -and poly- l -lactic acid, which represent the first generation of thermoplastic biodegradable polymers, have been researched as a substitute to traditional implants, avoiding the necessity of a second surgery to remove the implant. , These materials are free from toxic and mutagenic effects, but they also have several issues, most importantly mechanical stiffness, unfavorable tissue responses, and foreign body reactions. , On the other side, natural polymers, such as polysaccharides, are very similar in composition to the components of the native ECM, avoiding toxicity and immunological reactions, but they are also deficient in mechanical properties, which are fundamental to effectively mimic and support the tissue during the regeneration process and to induce the mechanotransduction of cell response, fundamental for the stimulation of specific stem cell differentiation. , For these reasons, new synthetic polymers, such as thermoplastic polyurethane (TPU), are of special interest as they allow the production of scaffolds with controlled elastic and mechanical properties that could guarantee an effective support during the new tissue formation . Medical-grade TPUs have been used in implantable medical devices for decades, but recently, there has been an increasing interest in their application in tissue engineering, as they allow easier handling and suturing and they also possess good blood compatibility and resistance to microorganism colonization and infection. − …”